Neoadjuvant hormone therapy plus robot-assisted radical prostatectomy improves pathologic outcomes in high-risk prostate cancer: a retrospective cohort study.

BMC Urol · 2026 · PMC13262519 · PMID 42050599

Europe PMC DOI

hedged sentence

0.3150

closest p · 6.3× alpha

0.3150

boldest claim

The sentences

a decreasing trendp = 0.315not close (p > 0.1)

In the NHT + RP group, the PV showed a decreasing trend after NHT treatment (46.07 ± 29.50 vs. 37.70 ± 31.14 ml, p = 0.315), with a median percentage reduction of 32.17% (IQR: 7.87–71.47%).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.